GGHC
LUNG icon

Gilder Gagnon Howe & Co’s Pulmonx LUNG Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,006,299
Closed -$36.2M – 409
2021
Q3 		$36.2M Sell
1,006,299
-39,403
-4% -$1.55M 0.19% 118
2021
Q2 		$46.1M Sell
1,045,702
-2,619
-0.2% -$114K 0.23% 109
2021
Q1 		$48M Sell
1,048,321
-54,281
-5% -$3.11M 0.26% 102
2020
Q4 		$76.1M Buy
+1,102,602
New +$54M 0.38% 82

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
MGM
Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Gilder Gagnon Howe & Co's LUNG Position: Q4 2021 in Review

Gilder Gagnon Howe & Co sold out of Pulmonx (LUNG) in Q4 2021, closing a stake of 1,006,299 shares — an estimated $36.2M sold.

Gilder Gagnon Howe & Co first reported a position in LUNG in Q4 2020 and held it in 4 quarters. The position peaked at $76.1M in Q4 2020. 114 funds tracked by Wall St. Rank hold LUNG as of Q4 2021.

  • Gilder Gagnon Howe & Co reported no remaining Pulmonx position as of Q4 2021 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 1,006,299 Pulmonx shares in Q4 2021, an estimated $36.2M.
  • Gilder Gagnon Howe & Co first reported a position in Pulmonx in Q4 2020 and held it in 4 quarters.
  • Gilder Gagnon Howe & Co's Pulmonx position peaked at $76.1M in Q4 2020.
  • 114 funds tracked by Wall St. Rank held Pulmonx as of Q4 2021.

Based on Gilder Gagnon Howe & Co's 13F filing for Q4 2021, filed 14 Feb 2022.